These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34902064)
1. Sleep Apnea and Cardiovascular Disease. Gottlieb DJ Curr Diab Rep; 2021 Dec; 21(12):64. PubMed ID: 34902064 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular consequences of obstructive sleep apnea. Ayas NT; Taylor CM; Laher I Curr Opin Cardiol; 2016 Nov; 31(6):599-605. PubMed ID: 27652812 [TBL] [Abstract][Full Text] [Related]
3. Hypertension in obstructive sleep apnea: risk and therapy. Das AM; Khayat R Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):619-26. PubMed ID: 19505277 [TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the Hyperglycemic Profiles in Obstructive Sleep Apnea (HYPNOS) trial. Rooney MR; Aurora RN; Wang D; Selvin E; Punjabi NM Contemp Clin Trials; 2021 Feb; 101():106248. PubMed ID: 33316455 [TBL] [Abstract][Full Text] [Related]
5. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Phillips CL; Cistulli PA Minerva Med; 2006 Aug; 97(4):299-312. PubMed ID: 17008835 [TBL] [Abstract][Full Text] [Related]
6. Consequences of Obstructive Sleep Apnea: Cardiovascular Risk of Obstructive Sleep Apnea and Whether Continuous Positive Airway Pressure Reduces that Risk. Khayat R; Pleister A Sleep Med Clin; 2016 Sep; 11(3):273-86. PubMed ID: 27542874 [TBL] [Abstract][Full Text] [Related]
7. Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea. Martínez-Ceron E; Fernández-Navarro I; Garcia-Rio F Sleep Med Rev; 2016 Feb; 25():121-30. PubMed ID: 26146025 [TBL] [Abstract][Full Text] [Related]
8. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. Barbé F; Durán-Cantolla J; Sánchez-de-la-Torre M; Martínez-Alonso M; Carmona C; Barceló A; Chiner E; Masa JF; Gonzalez M; Marín JM; Garcia-Rio F; Diaz de Atauri J; Terán J; Mayos M; de la Peña M; Monasterio C; del Campo F; Montserrat JM; JAMA; 2012 May; 307(20):2161-8. PubMed ID: 22618923 [TBL] [Abstract][Full Text] [Related]
11. Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea. Gervès-Pinquié C; Bailly S; Goupil F; Pigeanne T; Launois S; Leclair-Visonneau L; Masson P; Bizieux-Thaminy A; Blanchard M; Sabil A; Jaffuel D; Racineux JL; Trzepizur W; Gagnadoux F Am J Respir Crit Care Med; 2022 Dec; 206(11):1393-1404. PubMed ID: 35816570 [No Abstract] [Full Text] [Related]
12. Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for Treatment. Schillaci G; Battista F; Fiorenzano G; Basili MC; Crapa M; Alrashdi Y; Pucci G Curr Pharm Des; 2015; 21(24):3496-504. PubMed ID: 26144938 [TBL] [Abstract][Full Text] [Related]
13. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. Drager LF; Togeiro SM; Polotsky VY; Lorenzi-Filho G J Am Coll Cardiol; 2013 Aug; 62(7):569-76. PubMed ID: 23770180 [TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnea and cardiovascular disease, a story of confounders! Collen J; Lettieri C; Wickwire E; Holley A Sleep Breath; 2020 Dec; 24(4):1299-1313. PubMed ID: 31919716 [TBL] [Abstract][Full Text] [Related]
15. Sleep-disordered breathing and resistant hypertension. Wang AY Semin Nephrol; 2014; 34(5):520-31. PubMed ID: 25416661 [TBL] [Abstract][Full Text] [Related]
16. Rationale and Methodology of the SARAH Trial: Long-Term Cardiovascular Outcomes in Patients With Resistant Hypertension and Obstructive Sleep Apnea. Sapiña-Beltrán E; Torres G; Martínez-Alonso M; Sánchez-de-la-Torre M; Franch M; Bravo C; Masa JF; Felez M; Fortuna-Gutierrez AM; Abad J; García-Río F; Drager LF; Lee Chi-Hang R; Martínez-García MÁ; Barbé F; Dalmases M Arch Bronconeumol (Engl Ed); 2018 Oct; 54(10):518-523. PubMed ID: 29801678 [TBL] [Abstract][Full Text] [Related]
17. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Wolf J; Lewicka J; Narkiewicz K Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):233-40. PubMed ID: 17314035 [TBL] [Abstract][Full Text] [Related]
18. Continuous Positive Airway Pressure Treatment, Glycemia, and Diabetes Risk in Obstructive Sleep Apnea and Comorbid Cardiovascular Disease. Loffler KA; Heeley E; Freed R; Meng R; Bittencourt LR; Gonzaga Carvalho CC; Chen R; Hlavac M; Liu Z; Lorenzi-Filho G; Luo Y; McArdle N; Mukherjee S; Yap HS; Zhang X; Palmer LJ; Anderson CS; McEvoy RD; Drager LF; Diabetes Care; 2020 Aug; 43(8):1859-1867. PubMed ID: 32291275 [TBL] [Abstract][Full Text] [Related]